Wanglong Deng

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

Yongxiang Xia, Weiwei Tang, Xiaofeng Qian et al. · Journal for ImmunoTherapy of Cancer · 2022 · 211 citations · Full text

Medicine, Oncology, Pharmacology +17

A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing

Lizhen Zhu, Yanqin Huang, Xuefeng Fang et al. · Journal of Molecular Diagnostics · 2017 · 129 citations · Full text

Life Sciences, Genetics, Oncology +17

General mechanism of JQ1 in inhibiting various types of cancer

Guojuan Jiang, Wanglong Deng, Yang Liu et al. · Molecular Medicine Reports · 2020 · 59 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth

Shenghong Ma, Bowen Jiang, Wanglong Deng et al. · Oncotarget · 2015 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +12

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma

Lianghong Teng, Wanglong Deng, Junliang Lu et al. · Oncotarget · 2017 · 55 citations · Full text

Medicine, Genetics, Molecular Genetics +17